سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Turner, Alexander, Jones, Hunter, Serbin, Philip, Sambandam, Senthil. (1403). The Impact of Preoperative Co-morbidities on Blood Transfusion Requirements Following Reverse Total Shoulder Arthroplasty. , 12(7), 487-493. doi: 10.22038/abjs.2024.78961.3625
Alexander C. Turner; Hunter B. Jones; Philip A. Serbin; Senthil M. Sambandam. "The Impact of Preoperative Co-morbidities on Blood Transfusion Requirements Following Reverse Total Shoulder Arthroplasty". , 12, 7, 1403, 487-493. doi: 10.22038/abjs.2024.78961.3625
Turner, Alexander, Jones, Hunter, Serbin, Philip, Sambandam, Senthil. (1403). 'The Impact of Preoperative Co-morbidities on Blood Transfusion Requirements Following Reverse Total Shoulder Arthroplasty', , 12(7), pp. 487-493. doi: 10.22038/abjs.2024.78961.3625
Turner, Alexander, Jones, Hunter, Serbin, Philip, Sambandam, Senthil. The Impact of Preoperative Co-morbidities on Blood Transfusion Requirements Following Reverse Total Shoulder Arthroplasty. , 1403; 12(7): 487-493. doi: 10.22038/abjs.2024.78961.3625

The Impact of Preoperative Co-morbidities on Blood Transfusion Requirements Following Reverse Total Shoulder Arthroplasty

The Archives of Bone and Joint Surgery
مقاله 5، دوره 12، شماره 7، مهر 2024، صفحه 487-493    اصل مقاله (783.36 K)
نوع مقاله: RESEARCH PAPER
شناسه دیجیتال (DOI): 10.22038/abjs.2024.78961.3625
نویسندگان
Alexander C. Turner* 1؛ Hunter B. Jones2؛ Philip A. Serbin2؛ Senthil M. Sambandam2
1University of Texas Southwestern Medical Center, Dallas, Texas, USA
2Department of Orthopedic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
چکیده
Objectives: Reverse total shoulder arthroplasty (RTSA) continues to increase in popularity as a surgical 
operation in the United States. As indications for this procedure expand, more attention is needed to 
evaluate perioperative risk factors and patient characteristi cs. Postoperative anemia requiring blood 
transfusion (BT) is a well-documented risk factor for increased in-house mortality although little has 
been studied on the relationship between RTSA and postoperative BT. The purpose of this study was 
to identify comorbidities and patient characteristics as risk factors for BT in patient’s undergoing RTSA.
Methods: Using the Nationwide Inpatient Sample (NIS) database, 59,925 RTSA patients (2016-2019) were 
analyzed, with 1.96% requiring postoperative BT. Demographics, comorbidities, and preoperative factors were 
compared between BT and non-BT groups via univariate and multivariate analyses.
Results: Overall prevalence of blood transfusion in all patients was 1.96%. Male sex (OR 1.75, p < 0.001), Asian 
ethnicity (OR 1.96, p = 0.012), age >80 (OR 1.51, p < 0.001), age >90 (OR 2.26, p < 0.001), CKD (OR 1.94, p < 
0.001), and Parkinson’s disease (OR 2.08, p < 0.001) were associated with increased BT odds. Cirrhosis exhibited 
the highest impact (OR 5.7, p < 0.001). Conversely, Caucasian ethnicity (OR 0.76, p = 0.023), uncomplicated DM 
(OR 0.73, p = 0.002), tobacco-related disorders (OR 0.43, p < 0.001), BMI >30 (OR 0.8, p = 0.011), and elective 
procedures (OR 0.16, p < 0.001) decreased BT odds.
Conclusion: These results were useful with identifying several risk factors that predispose to a higher risk of 
postoperative BT in patients undergoing RTSA including male sex, people of Asian descent, age > 80, CKD, 
Parkinson’s disease, and cirrhosis. These findings provide clinicians with information that may be helpful with 
preoperative planning and perioperative management of complex patient populations.
 Level of evidence: III
کلیدواژه‌ها
Blood transfusion requirements؛ Nationwide inpatient sample؛ Preoperative co-morbidities؛ Reverse Total Shoulder Arthroplasty
مراجع
  1. Hermena S, Rednam M. Reverse shoulder arthroplasty. StatPearls [Internet]. Accessed 2024.
  2. Kim SC, Kim IS, Jang MC, Yoo JC. Complications of reverse shoulder arthroplasty: A concise review. Clin Shoulder Elb. 2021; 24(1):42-52. doi: 10.5397/cise.2021.00066.
  3. Mayfield CK, Korber SS, Hwang NM, et al. Volume, indications, and number of surgeons performing reverse total shoulder arthroplasty continue to expand: A nationwide cohort analysis from 2016-2020. JSES Int. 2023; 7(5):827-834. doi: 10.1016/j.jseint.2023.05.002.
  4. Shoulder replacement surgery. HonorHealth. Available at: https://www.honorhealth.com/medical-services/orthopedics/shoulder-replacement-surgery. Accessed April 3, 2024.
  5. Vaquero-Picado A, Antuña S, Barco R. Revision total shoulder arthroplasty: Complications and results. Revision Total Joint Arthroplasty. 2020:107-14. doi: 10.1007/978-3-030-24773-7_9.
  6. Zumstein MA, Pinedo M, Old J, Boileau P. Problems, complications, reoperations, and revisions in reverse total Shoulder Arthroplasty: A systematic review. J Shoulder Elbow Surg. 2011; 20(1):146-57. doi: 10.1016/j.jse.2010.08.001.
  7. Shah SS, Gaal BT, Roche AM, et al. The modern reverse shoulder arthroplasty and an updated systematic review for each complication: Part I. JSES Int. 2020;4(4):929-943. doi: 10.1016/j.jseint.2020.07.017.
  8. Smeets SJ, Verbruggen JP, Poeze M. Effect of blood transfusion on survival after hip fracture surgery. Eur J Orthop Surg Traumatol. 2018; 28(7):1297-1303. doi: 10.1007/s00590-018-2205-z.
  9. Kalra SK, Thilagar B, Khambaty M, Manjarrez E. Post-operative anemia after major surgery: A brief review. Current Emergency and Hospital Medicine Reports. 2021; 9(3):89-95. doi:10.1007/s40138-021-00232-x.
  10. Dao P, Massin P. Blood management in enhanced recovery after hip and knee replacement. Orthop Traumatol Surg Res.2020; 106(1S):S1-S5. doi: 10.1016/j.otsr.2019.05.022.
  11. Flurin PH, Roche CP, Wright TW, Marczuk Y, Zuckerman JD. A Comparison and Correlation of Clinical Outcome Metrics in Anatomic and Reverse Total Shoulder Arthroplasty. Bull Hosp Jt Dis (2013).2015:73 Suppl 1:S118-23.
  12. Paras T, Raines B, Kohut K, et al. Clinical outcomes of reverse total shoulder arthroplasty for elective indications versus acute 3- and 4-part proximal humeral fractures: a systematic review and meta-analysis. J Shoulder Elbow Surg.2022;31(1):e14-e21. doi: 10.1016/j.jse.2021.07.014.
  13. Galvin JW, Kim R, Ment A, et al. Outcomes and complications of primary reverse shoulder arthroplasty with minimum of 2 years' follow-up: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2022; 31(11):e534-e544. doi:10.1016/j.jse.2022.06.005.
  14. Bacle G, Nové-Josserand L, Garaud P, Walch G. Long-Term Outcomes of Reverse Total Shoulder Arthroplasty: A Follow-up of a Previous Study. J Bone Joint Surg Am. 2017; 99(6):454-461. doi:10.2106/JBJS.16.00223.
  15. Chalmers PN, Boileau P, Romeo AA, Tashjian RZ. Revision Reverse Shoulder Arthroplasty. J Am Acad Orthop Surg. 2019; 27(12):426-436. doi:10.5435/JAAOS-D-17-00535.
  16. Ahmadi S, Lawrence TM, Sahota S, et al. The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution's experience and review of the literature. J Shoulder Elbow Surg. 2014; 23(1):43-48. doi:10.1016/j.jse.2013.03.010.
  17. Sperling JW, Duncan SF, Cofield RH, Schleck CD, Harmsen WS. Incidence and risk factors for blood transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2005; 14(6):599-601. doi:10.1016/j.jse.2005.03.006.
  18. Millett PJ, Porramatikul M, Chen N, Zurakowski D, Warner JJ. Analysis of transfusion predictors in shoulder arthroplasty. J Bone Joint Surg Am. 2006; 88(6):1223-1230. doi:10.2106/JBJS.E.00706.
  19. Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL. Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg. 2009; 18(2):225-230. doi:10.1016/j.jse.2008.08.005.
  20. Hays CE, Pharr ZK, Goedecke PJ, et al. Does the transfusion rate following reverse total shoulder arthroplasty warrant aggressive perioperative blood management? An indications-based analysis. Seminars in Arthroplasty: JSES. 2023; 33(1):1-7. doi:10.1053/j.sart.2022.07.013.
  21. Healthcare Cost and Utilization Project - National (Nationwide) Inpatient Sample (HCUP-NIS). Agency for Healthcare Research and Quality (AHRQ). Available at: https://health.gov/healthypeople/objectives-and-data/data-sources-and-methods/data-sources/healthcare-cost-and-utilization-project-national-nationwide-inpatient-sample-hcup-nis. Accessed April 3, 2024.
  22. Salt E, Wiggins AT, Rayens MK, et al. Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis. J Clin Rheumatol. 2018;24(8):422-426. doi:10.1097/RHU.0000000000000755.
  23. Kesler KK, Brown TS, Martin JR, Springer BD, Otero J. Risk factors for blood transfusion after primary total hip arthroplasty. Reconstructive Review. 2019; 9. doi:10.15438/rr.9.1.226.
  24. Wang J, Wang Y, Zhou W, Huang Y, Yang J. Impacts of cigarette smoking on blood circulation: Do we need a new approach to blood donor selection? J Health Popul Nutr. 2023; 42(1):62. doi: 10.1186/s41043-023-00405-2.
  25. Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev. 2009; 10(5):554-563. doi:10.1111/j.1467-789X.2009.00593.x.
  26. de Laat-Kremers R, Di Castelnuovo A, van der Vorm L, et al. Increased BMI and Blood Lipids Are Associated with a Hypercoagulable State in the Moli-sani Cohort. Front Cardiovasc Med. 2022:9:897733. doi:10.3389/fcvm.2022.897733.
  27. O'Donnell FT. Preoperative Evaluation of the Surgical Patient. Mo Med. 2016; 113(3):196-201.
  28. Jindal P, Patil V, Pradhan R, Mahajan HC, Rani A, Pabba UG. Update on preoperative evaluation and optimisation. Indian J Anaesth. 2023; 67(1):39-47. doi:10.4103/ija.ija_1041_22.
  29. Cole WW, Familia M, Miskimin C, Mulcahey MK. Preoperative Optimization and Tips to Avoiding Surgical Complications Before the Incision. Sports Med Arthrosc Rev. 2022; 30(1):2-9. doi:10.1097/JSA.0000000000000336.
  30. Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020; 192:40-51. doi:10.1016/j.thromres.2020.05.008.
  31. Lee D, Lee R, Fassihi SC, et al. Risk Factors for Blood Transfusions in Primary Anatomic and Reverse Total Shoulder Arthroplasty for Osteoarthritis. Iowa Orthop J. 2022; 42(1):217-225.
  32. De Santo LS, Romano G, Mango E, et al. Age and blood transfusion: Relationship and prognostic implications in cardiac surgery. J Thorac Dis. 2017; 9(10):3719-3727. doi:10.21037/jtd.2017.08.126.
  33. Bolognesi MP, Marchant MH Jr, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008; 23(6 Suppl 1):92-98. doi:10.1016/j.arth.2008.05.012.
  34. Taderegew MM, Gebremariam T, Tareke AA, Woldeamanuel GG. Anemia and Its Associated Factors among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study. J Blood Med. 2020:11:47-58. doi:10.2147/JBM.S243234.
  35. Soliman AT, De Sanctis V, Yassin M, Soliman N. Iron deficiency anemia and glucose metabolism. Acta Biomed. 2017; 88(1):112-118. doi:10.23750/abm.v88i1.6049.
  36. Christy AL, Manjrekar PA, Babu RP, Hegde A, Rukmini MS. Influence of iron deficiency anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iran Biomed J. 2014; 18(2):88-93. doi:10.6091/ibj.1257.2014.
  37. Gauci R, Hunter M, Bruce DG, Davis WA, Davis TME. Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis. J Diabetes Complications.2017; 31(7):1169-1174. doi:10.1016/j.jdiacomp.2017.04.002.
  38. Fox HM, Best MJ, Mikula JD, Aziz KT, Srikumaran U. Short-Term Complications and Readmission Following Total Shoulder Arthroplasty: A National Database Study. Arch Bone Jt Surg.2021; 9(3):323-329. doi: 10.22038/abjs.2020.48852.2426.
  39. Williams AA, Tischler EH, Sholder D, et al. Identification of Risk Factors for Abnormal Postoperative Chemistry Labs after Primary Shoulder Arthroplasty. Arch Bone Jt Surg. 2018; 6(4):282-288. doi: 10.22038/abjs.2018.26686.1706.
 

 

 

 

 

 

آمار
تعداد مشاهده مقاله: 415
تعداد دریافت فایل اصل مقاله: 344